Exchange rate hurting chronic drug suppliers – but ARV pipeline safe, says govt
The government has categorically denied that there is any danger of antiretroviral (ARV) drug supplies running short or drying up following a claim from one of their three suppliers, Aspen Pharmaceuticals, that insufficient relief on the dismal rand exchange rate and single exit price (SEP) is creating a net loss.
Chris Bateman, HMPG, South Africa
Full TextPDF (103KB)
Cite this article
Date published: 2014-06-10
Full text views: 825